Browse Title Index
| Issue | Title | |
| Vol 11, No 3 (2020) | Pytania testowe | Details |
| Pytania testowe | ||
| Vol 11, No 4 (2020) | Pytania testowe | Details PDF (Polish) |
| Pytania testowe | ||
| Vol 5, No 2 (2014) | Quality of life of patients suffering from primary myelofibrosis is important parameter in assessment of treatment efficacy | Abstract PDF (Polish) HTML (Polish) |
| Tomasz Sacha | ||
| Vol 11, Supp. A (2020) | Rapid molecular recurrence after nilotinib therapy cessation | Abstract PDF (Polish) |
| Joanna Wącław, Tomasz Sacha | ||
| Vol 13, No 3-4 (2022) | Recommendations for prevention of SARS-CoV-2 infection in immunocompromised patients | Details PDF |
| Krzysztof Tomasiewicz, Alicja Dębska-Ślizień, Magdalena Durlik, Krzysztof Giannopoulos, Iwona Hus, Piotr Rutkowski | ||
| Vol 3, No 2 (2012) | Red blood cell membranopathies — pathogenesis, clinical presentation and diagnosis | Abstract PDF (Polish) |
| Justyna Spychalska | ||
| Vol 2, No 1 (2011) | Reed-Sternberg cell microenvironment in classical Hodgkin lymphoma — pathogenetic role and therapeutic target | Abstract PDF (Polish) |
| Przemysław Juszczyński | ||
| Vol 9, No 3 (2018) | Renal amyloidosis | Abstract PDF (Polish) |
| Wojciech Wołyniec, Agnieszka Perkowska-Ptasińska, Alicja Dębska-Ślizień, Tomasz Liberek, Magdalena Durlik | ||
| Vol 9, No 2 (2018) | Renal cell carcinoma in patients with multiple myeloma – 2 case reports and review of literature | Abstract PDF (Polish) |
| Agnieszka Ożańska, Marta Sobas, Magdalena Olszewska-Szopa, Tomasz Wróbel | ||
| Vol 5, No 1 (2014) | Resistance mechanisms of hematopoietic and leukemic stem cells | Abstract PDF (Polish) HTML (Polish) |
| Agnieszka Ciomber, Iwona Mitrus | ||
| Vol 4, No 1 (2013) | Reversible pulmonary arterial hypertension as a complication of dasatinib treatment, with effi cacious and safe continuation of chronic myeloid leukaemia therapy with nilotinib | Abstract PDF (Polish) |
| Elżbieta Patkowska, Ewa Lech-Marańda, Szymon Darocha, Marcin Kurzyna, Adam Torbicki, Krzysztof Warzocha | ||
| Vol 11, No 2 (2020) | Review of information on COVID-19 disease and the SARS-CoV-2 | Abstract PDF (Polish) |
| Justyna Błach, Jacek Roliński | ||
| Vol 3, No 4 (2012) | Rituximab maintenance treatment in first and further remissions in patients with follicular lymphoma | Abstract PDF (Polish) |
| Ewa Kalinka-Warzocha, Ewa Lech-Marańda | ||
| Vol 9, No 4 (2018) | Role and therapeutic potential of sphingolipids signaling in hematological malignances | Abstract PDF (Polish) |
| Marzena Wątek, Bonita Durnaś, Tomasz Wollny, Małgorzata Żendzian-Piotrowska, Marcin Pasiarski, Stanisław Góźdź | ||
| Vol 3, No 1 (2012) | Role of allogeneic hematopoietic stem cell transplantation in the treatment of patients with lymphoma | Abstract PDF (Polish) |
| Tomasz Czerw | ||
| Vol 9, No 2 (2018) | Role of drugs influencing epigenetic mechanisms in acute myeloid leukemia treatment | Abstract PDF (Polish) |
| Kamil Wiśniewski, Joanna Góra-Tybor | ||
| Vol 2, No 3 (2011) | Role of maintenance therapy in the treatment of plasma cell myeloma | Abstract PDF (Polish) |
| Krzysztof Jamroziak | ||
| Vol 10, No 4 (2019) | Role of midostaurin in treatment of acute myeloid leukemia harbouring FLT3 mutation | Abstract PDF (Polish) |
| Agnieszka Wierzbowska, Magdalena Czemerska | ||
| Vol 14 (2023): Continuous Publishing | Ruxolitinib as a primary treatment for multiple myeloma in a patient with primary myelofibrosis? A case report and the review of the literature | Abstract PDF |
| Przemysław Zygmunciak, Justyna Iskrzak, Joanna Góra-Tybor, Ewa Lech-Marańda, Bartosz Puła | ||
| Vol 9, No 4 (2018) | Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers | Details PDF (Polish) |
| Krzysztof Warzocha, Wojciech Homenda, Andrzej Pluta, Tomasz Sacha, Maria Cioch, Marek Dudziński, Dorota Krochmalczyk, Joanna Góra-Tybor, Ilona Seferyńska, Monika Joks, Marta Sobas | ||
| Vol 10, Supp. A (2019) | Ruxolitinib treatment in a patient with primary myelofibrosis and thrombocytopenia | Abstract PDF (Polish) |
| Paweł Chrząstek, Dariusz Woszczyk | ||
| Vol 10, Supp. A (2019) | Ruxolitinib withdrawal syndrome in a patient with myelofibrosis | Abstract PDF (Polish) |
| Ilona Seferyńska, Krzysztof Warzocha | ||
| Vol 11, No 3 (2020) | Safety and efficacy of venetoclax–rituximab protocol after BTK inhibitor treatment in a patient with chronic lymphocytic leukemia | Abstract PDF (Polish) |
| Joanna Ewa Drozd-Sokołowska, Grzegorz Władysław Basak | ||
| Vol 3, No 1 (2012) | Safety of hematopoietic stem cell donors | Abstract PDF (Polish) |
| Jan Styczyński | ||
| Vol 4, No 4 (2013) | Secondary acute myeloid leukemia after successful treatment of acute promyelocytic leukemia | Abstract PDF (Polish) HTML (Polish) |
| Agnieszka Wierzbowska, Ewa Wawrzyniak, Anna Szmigielska-Kapłon, Magdalena Czemerska, Olga Grzybowska-Izydorczyk, Konrad Stępka, Agnieszka Pluta, Tadeusz Robak | ||
| 376 - 400 of 543 Items | << < 11 12 13 14 15 16 17 18 19 20 > >> | |
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl
